首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Current Pharmaceutical Design

Current Pharmaceutical Design杂志,由Bentham Science Publishers B.V.出版,于1995年创刊,Biweekly,出版语言English,ISSN:1381-6128,E-ISSN:1873-4286。

投稿咨询
Current Pharmaceutical Design
Current Pharmaceutical Design
Current Pharmaceutical Design
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
4区
影响因子
3.2
CiteScore
5.8
期刊收录
SCI、SCIE

Current Pharmaceutical Design(中文译名:《当前的药物设计》),ISSN:1381-6128,EISSN:1873-4286,是Bentham Science Publishers B.V.出版的国际性学术期刊,创刊于1995年,以Biweekly形式稳定发行,2026年总发文量约339篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.2,2025年期刊CiteScore为5.8,2025年期刊自引率约3.1%,在中科院期刊分区体系中位列医学大类4区,在所属学科领域具备高学术影响力与国际认可度。Current Pharmaceutical Design长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约2月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、India、Italy、Brazil、Greece、Iran等为核心发文国家与地区;

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 156 / 356

56.3

学科:PHARMACOLOGY & PHARMACY SCIE Q3 237 / 356

33.57

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 157 / 352

55.5

学科:PHARMACOLOGY & PHARMACY SCIE Q3 236 / 353

33.29


中国学者近期发文

1
Efficacy and Safety of Finerenone for Renal and Cardiovascular Events in Diabetic Kidney Disease: A Meta-analysi

Author:Chen, Wenmin; Zheng, Lingqian; Lin, Yongda; Liao, Chunling; Zhou, Tianbiao

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128433708251128041537

2
Network Pharmacology, Molecular Docking, and Experimental Validation Reveal the Mechanism of Qingfudaotan Formula in PCOS Treatmen

Author:Wang, Ruye; Chen, Yun; Zhu, Menglei; Jin, Shengyue; Zhao, Ying; Miao, Chenyun; Ren, Ning; Yang, Liuqin; Fang, Xiaohong; Zhang, Qin

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128410423251124071922

3
Meta-Analysis of the Differences in Effectiveness and Safety of Iron-Based Phosphate Binders and Non-Calcium Phosphate Binder

Author:Lin, Yongda; Huang, Shuangyi; Yao, Kaijin; Chen, Wenmin; Zheng, Lingqian; Zhou, Tianbiao

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128434352260106060134

4
Advances in Cell Membrane Biomimetic Nano-Delivery Systems for Brain Tumor Therap

Author:Zhou, Wenbo; Liu, Ruiyao; Dai, Wuting; Guo, Lingyi; Yu, Yuan

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128417270251125062956

5
Chebulinic Acid Exerts Anti-rotavirus Effects through the p38MAPK/ERK1/2 Signaling Pathwa

Author:Yu, Junxian; Zhang, Didong; Qian, Yupei; Ruan, Yongdui; Zhou, Yunmei; Jiang, Xiaoying; Liu, Fenglin; Zhou, Jie; Rong, Ziyi; He, Ziyue; Song, Lijun; Zhao, Wenchang

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128431943251206212256

6
Review on the Potential Anti-aging Effects of Gastrodia elat

Author:Wang, Ruoying; Xin, Chenran; Liu, Wencong; Cheng, Zhiqiang; Zhu, Hongyan; Han, Jihong

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128428972251204212438

7
Elucidating the Anti-thrombotic Mechanism of Equiseti hiemalis Herba through Integrated Pharmacolog

Author:Song, Zhenguang; Hu, Yi; Xu, Yingbi; Yang, Yitong; Li, Qian; Ma, Yuhan; Guo, Xiangxin; Yan, Zhuyun

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128428436251205122528

8
Unlocking the Role of Exosomal ncRNAs in Colorectal Cancer: Molecular Insights and Clinical Promis

Author:Eltaib, Lina; Zhang, Liming; Khan, Yumna; Alanazi, Mashael N.; Elhassan, Gamal Osman; Rana, Amita Joshi; Maqbool, Mudasir; Hussain, Md Sadique

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128415658251125090944

9
Physcion Alleviates Osteoporotic Bone Loss by Inhibiting Osteoclast Formation and Promoting Osteoblast Differentiatio

Author:Fan, Jing; Hu, Yaqian; Yin, Jinhua; Gao, Chu; Zhao, Chengxiang; Zheng, Chao; Yang, Liu; Lu, Weiguang

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128428298251129125513

10
Impact of Volatile Organic Compounds on Liver Function in Adolescents: Mediation and Preventive Insights from NHANE

Author:Yao, Xiaodie; You, Congwei; Zhou, Min; Zhou, Huan; Tang, Cai; Zhang, Haoyang; Wang, Xiaolei; Jin, Weilai; Zhang, Le

Journal: CURRENT PHARMACEUTICAL DESIGN. 2026; Vol. , Issue , pp. -. DOI: 10.2174/0113816128431488251204105511


在线咨询

Current Pharmaceutical Design

国际简称:CURR PHARM DESIGN参考译名:当前的药物设计

年发文量:339 CiteScore:5.8 是否预警:否 Gold OA文章占比:4.50% 研究类文章占比:42.18%

杂志社联系方式:BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR

Current Pharmaceutical Design